IL92735A - Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same - Google Patents

Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same

Info

Publication number
IL92735A
IL92735A IL92735A IL9273589A IL92735A IL 92735 A IL92735 A IL 92735A IL 92735 A IL92735 A IL 92735A IL 9273589 A IL9273589 A IL 9273589A IL 92735 A IL92735 A IL 92735A
Authority
IL
Israel
Prior art keywords
subjecting
purification
pooling
growth factor
cell growth
Prior art date
Application number
IL92735A
Other languages
English (en)
Other versions
IL92735A0 (en
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of IL92735A0 publication Critical patent/IL92735A0/xx
Publication of IL92735A publication Critical patent/IL92735A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL92735A 1988-12-20 1989-12-15 Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same IL92735A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28805688A 1988-12-20 1988-12-20

Publications (2)

Publication Number Publication Date
IL92735A0 IL92735A0 (en) 1990-09-17
IL92735A true IL92735A (en) 1998-06-15

Family

ID=23105561

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92735A IL92735A (en) 1988-12-20 1989-12-15 Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same

Country Status (13)

Country Link
EP (2) EP0685490A1 (da)
JP (1) JPH02288897A (da)
KR (1) KR900009989A (da)
AT (1) ATE145242T1 (da)
AU (1) AU4687989A (da)
CA (1) CA2005600A1 (da)
DE (1) DE68927458T2 (da)
DK (1) DK643389A (da)
FI (1) FI896137A7 (da)
IL (1) IL92735A (da)
NO (1) NO895055L (da)
NZ (1) NZ231837A (da)
PT (1) PT92613B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI890342L (fi) * 1988-01-25 1989-07-26 American Cyanamid Co Hjaernmitogener, som binds till heparin.
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
ES2123004T3 (es) * 1991-04-12 1999-01-01 Creative Biomolecules Inc Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales.
DE4118912C1 (da) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
GB9121815D0 (en) * 1991-10-15 1991-11-27 Delta Biotechnology Ltd Medicine
EP0697883A1 (en) * 1993-04-29 1996-02-28 Washington University Use of platelet-derived growth factor to improve collateral circulation
JP3268147B2 (ja) * 1994-12-28 2002-03-25 大鵬薬品工業株式会社 モノクローナル抗体
AU729459B2 (en) * 1996-11-15 2001-02-01 Genentech Inc. Purification of neurotrophins
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AUPP263498A0 (en) * 1998-03-27 1998-04-23 Walter And Eliza Hall Institute Of Medical Research, The Novel therapeutic molecules and uses therefor
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
WO2012102100A1 (ja) 2011-01-26 2012-08-02 雪印メグミルク株式会社 感覚改善剤
HK1221402A1 (zh) 2013-04-02 2017-06-02 University Of Florida Research Foundation, Inc. 用於诱导并调节血管生成的组合物和方法以及用於鉴别血管生成调节剂的方法和实验

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
DK643389A (da) 1990-06-21
DE68927458D1 (de) 1996-12-19
JPH02288897A (ja) 1990-11-28
PT92613B (pt) 1996-09-30
DK643389D0 (da) 1989-12-18
FI896137A7 (fi) 1990-06-21
EP0377855A2 (en) 1990-07-18
EP0685490A1 (en) 1995-12-06
EP0377855A3 (en) 1990-12-19
DE68927458T2 (de) 1997-04-03
CA2005600A1 (en) 1990-06-20
PT92613A (pt) 1990-06-29
KR900009989A (ko) 1990-07-06
NO895055D0 (no) 1989-12-15
IL92735A0 (en) 1990-09-17
EP0377855B1 (en) 1996-11-13
FI896137A0 (fi) 1989-12-20
AU4687989A (en) 1990-06-28
ATE145242T1 (de) 1996-11-15
NZ231837A (en) 1992-03-26
NO895055L (no) 1990-06-21

Similar Documents

Publication Publication Date Title
IL92735A (en) Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same
FI922824L (fi) Renat immunoglobulin.
NO945032L (no) Fremgangsmåte for fremstilling av et konsentrat av Anti-D-Immunglobulin D samt farmasöytisk preparat inneholdende dette
AU645094B2 (en) Method of treating bladder cancer cells
KR890701618A (ko) 단백질 정제방법
DE2924744C2 (de) Gewinnung von reiner Urokinase
EP0212688A3 (en) Substituted and crosslinked glucans, process for preparing them and use thereof
ES2093031T3 (es) Metodo para purificar el factor de crecimiento transformante (tgf).
CA2023405A1 (en) Process for purifying n-phosphonomethylglycine
EP0289129A3 (en) High purity protein a preparation
SE7909897L (sv) Rening av gammaglobulinderivat
DE3788170D1 (de) Methode zur Reinigung und Isolierung von zwei ionischen Formen von Somatomedin.
GR3004622T3 (da)
ES8304450A1 (es) Un metodo para regenerar una resina de intercambio cationico.
FR2616782B1 (fr) Procede de separation d'acides amines
Buday et al. Production of demineralized water and ammonium nitrate solution from effluents in ammonia production
JPS54138189A (en) Separation and purification of urokinase
TW260624B (en) Process of separating tryptophan (Trp) from zymotic fluid by ion-exchange displacement chromatography
RO103684A2 (en) PRODUCTION METHOD OF IMMUNO-GLOBULIN A1(IgA1)
FR2423987A1 (fr) Procede de preparation d'une substance proteinique a partir d'une levure, substance obtenue selon ce procede et son application dans le domaine de la nutrition
RU93037415A (ru) Способ промышленного получения (6s)-изомеров методом хроматографического разделения
DD215319A1 (de) Verfahren zur anreicherung von interferonen

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees